Medicamen Organics targets revenue of $2.5 Million for FY25 with Strategic Rwanda Expansion

Medicamen

New Delhi — Medicamen Organics Limited has announced an ambitious target to achieve $2.5 million in revenue by the fiscal year 2025, as part of its strategic expansion into East Africa. This announcement reflects the company’s focused strategy to expand its operations in emerging markets and drive substantial growth in the region. The company plans to establish a warehouse and depot in Kigali, which will function as a key hub for its distribution network across the region.

Ashutosh Gupta, Director of Medicamen Organics Limited and Past Chairman, of Pharmexcil Export Promotion Council of India, shared his optimism about the company’s growth prospects: “Rwanda is a vital market for our expansion into East Africa. With this $75,000 investment, we are on track to achieve our $2.5 million revenue target for FY25. The country’s strategic location and supportive business environment provide the perfect foundation for our growth in the region. This target not only reflects our confidence in the Rwandan market but also our commitment to delivering strong financial performance on a global scale.”

As part of its expansion into Rwanda, Medicamen Organics recently invested $75,000 and signed a Memorandum of Understanding (MoU) with Depot Pharmacy Yego Ltd. The investment will be used for capital expenditures and product registration, laying the groundwork for the company’s operations in Rwanda, including the establishment of a warehouse and depot in Kigali to support its regional distribution network.

In addition to its expansion plans, Medicamen Organics is enhancing its operational capabilities to support its growth targets. The company is investing in improving its infrastructure and streamlining its distribution processes to better serve the East African market. This focus on strengthening its operational framework is expected to drive efficiency, support the company’s revenue goals, and solidify its position in the region’s pharmaceutical industry.

You May Also Like

More From Author

+ There are no comments

Add yours